Human breast cancer-associated fibroblasts enhance cancer cell proliferation through increased TGF-α cleavage by ADAM17

Cancer Letters

Volumn 336, Issue 1, 2013, Pages 240-246

  Gao, Ming Qing ^a,b   Kim, Baek Gil ^a   Kang, Suki ^a   Choi, Yoon Pyo ^a   Yoon, Joo Heon ^a   Cho, Nam Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

ADAM17; Breast cancer; Cancer associated fibroblasts; Cell proliferation; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; BREAST CARCINOMA; CANCER ASSOCIATED FIBROBLAST; CANCER CELL CULTURE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

ADAM PROTEINS; BREAST; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84878964043     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.05.011     Document Type: Article

References (27)

1. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
2. Hawsawi N.M., Ghebeh H., Hendrayani S.F., Tulbah A., Al-Eid M., Al-Tweigeri T., Ajarim D., Alaiya A., Dermime S., Aboussekhra A. Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res. 2008, 68:2717-2725.
3. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
4. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
5. Noel A., Jost M., Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin. Cell Dev. Biol. 2008, 19:52-60.
6. Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat. Rev. Cancer 2008, 8:929-941.
7. Rocks N., Paulissen G., El Hour M., Quesada F., Crahay C., Gueders M., Foidart J.M., Noel A., Cataldo D. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 2008, 90:369-379.
8. Mochizuki S., Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007, 98:621-628.
9. Edwards D.R., Handsley M.M., Pennington C.J. The ADAM metalloproteinases. Mol. Aspects Med. 2008, 29:258-289.
10. Furth M.E., Christ G.J. Regenerative pharmacology for diabetes mellitus. Mol. Interv. 2009, 9:171-174.
11. McGowan P.M., Ryan B.M., Hill A.D., McDermott E., O'Higgins N., Duffy M.J. ADAM-17 expression in breast cancer correlates with variables of tumor progression. Clin. Cancer Res. 2007, 13:2335-2343.
12. Borrell-Pages M., Rojo F., Albanell J., Baselga J., Arribas J. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 2003, 22:1114-1124.
13. Maretzky T., Zhou W., Huang X.Y., Blobel C.P. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17. Oncogene 2011, 30:611-618.
14. Kenny P.A., Bissell M.J. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J. Clin. Invest. 2007, 117:337-345.
15. Gao M.Q., Kim B.G., Kang S., Choi Y.P., Park H., Kang K.S., Cho N.H. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J. Cell. Sci. 2010, 123:3507-3514.
16. Tyan S.W., Kuo W.H., Huang C.K., Pan C.C., Shew J.Y., Chang K.J., Lee E.Y., Lee W.H. Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis. PLoS ONE 2011, 6:e15313.
17. Humphreys R.C., Hennighausen L. Transforming growth factor alpha and mouse models of human breast cancer. Oncogene 2000, 19:1085-1091.
18. Lendeckel U., Kohl J., Arndt M., Carl-McGrath S., Donat H., Rocken C. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. J. Cancer Res. Clin. Oncol. 2005, 131:41-48.
19. Liu P.C., Liu X., Li Y., Covington M., Wynn R., Huber R., Hillman M., Yang G., Ellis D., Marando C., Katiyar K., Bradley J., Abremski K., Stow M., Rupar M., Zhuo J., Li Y.L., Lin Q., Burns D., Xu M., Zhang C., Qian D.Q., He C., Sharief V., Weng L., Agrios C., Shi E., Metcalf B., Newton R., Friedman S., Yao W., Scherle P., Hollis G., Burn T.C. Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells. Cancer Biol. Ther. 2006, 5:657-664.
20. Dittmer A., Hohlfeld K., Lutzkendorf J., Muller L.P., Dittmer J. Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10. Cell. Mol. Life Sci. 2009, 66:3053-3065.
21. Verbisck N.V., Costa E.T., Costa F.F., Cavalher F.P., Costa M.D., Muras A., Paixao V.A., Moura R., Granato M.F., Ierardi D.F., Machado T., Melo F., Ribeiro K.B., Cunha I.W., Lima V.C., Maciel Mdo S., Carvalho A.L., Soares F.F., Zanata S., Sogayar M.C., Chammas R., Camargo A.A. ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis. Cancer Res. 2009, 69:5546-5552.
22. Kikuchi K., Li X., Zheng Y., Takano Y. Invasion of breast cancer cells into collagen matrix requires TGF-alpha and Cdc42 signaling. FEBS Lett. 2011, 585:286-290.
23. Zheng X., Jiang F., Katakowski M., Zhang Z.G., Lu Q.E., Chopp M. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol. Ther. 2009, 8:1045-1054.
24. Schafer B., Marg B., Gschwind A., Ullrich A. Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J. Biol. Chem. 2004, 279:47929-47938.
25. Schafer B., Gschwind A., Ullrich A. Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 2004, 23:991-999.
26. Cherney R.J., King B.W., Gilmore J.L., Liu R.Q., Covington M.B., Duan J.J., Decicco C.P. Conversion of potent MMP inhibitors into selective TACE inhibitors. Bioorg. Med. Chem. Lett. 2006, 16:1028-1031.
27. Park K., Aplasca A., Du M.T., Sun L., Zhu Y., Zhang Y., Levin J.I. Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors. Bioorg. Med. Chem. Lett 2006, 16:3927-3931.